Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area

Annals of the Rheumatic Diseases

Volumn 60, Issue 6, 2001, Pages 566-572

  Hamilton, J ^a   McInnes, I B ^a   Thomson, E A ^b   Porter, D ^b   Hunter, J A ^b   Madhok, R ^a   Capell, H A ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FOLIC ACID; GOLD; METHOTREXATE;

ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SOCIOECONOMICS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GOLD SODIUM THIOMALATE; HEALTH STATUS INDICATORS; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PAIN MEASUREMENT; POVERTY AREAS; TREATMENT OUTCOME;

EID: 0035003318     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.6.566     Document Type: Article

References (40)

1. Parenteral gold therapy for rheumatoid arthritis: A treatment whose time has gone
2. Longterm drug treatment for rheumatoid arthritis in 7 rheumatology private practices II: Second-line drugs and prednisolone
3. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis
4. The efficacy of folic acid and folinic acid in reducing methotrexate GI toxicity in RA. A metaanalysis of randomised controlled trials
5. Psoriasis-liver-methotrexate interactions
6. Methotrexate and histologic hepatic abnormalities: A metaanalysis
7. The relationship of pre-existing lung disease to the development of methotrexate pneumonitis in patients with RA
8. Predictive value of pulmonary function tests in methotrexate induced pneumonitis in RA
9. Influence of sulphasalazine, methotrexate and combination of both on plasma homocysteine concentration in patients with RA
10. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity
11. The American Rheumatism Association 1987 revised criteria for the classification of RA
12. Clinical studies with an articular index for the assessment of joint tenderness in patients with RA
13. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis
14. A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive RA
15. The Cooperative Systematic Studies of the Rheumatic Diseases Group Analysis of improvement in individual RA patients treated with disease modifying anti rheumatic drugs based on the findings in patients treated with placebo
16. A double blind randomised parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis
17. Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis. A randomised double blind 26 week trial
18. A randomised controlled trial of parenteral methotrexate compared with sodium aurothiomalate (myochrysine) in the treatment of rheumatoid arthritis
19. Significant clinical remission in rheumatoid arthritis resulting from sensitivity produced by gold salt treatment
20. Association between gold induced skin rash and remission in patients with rheumatoid arthritis
21. Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate
22. Second line (disease modifying) treatment in rheumatoid arthritis: Which drug for which patient?
23. Sulphasalazine in rheumatoid arthritis: A double blind comparison of sulphasalazine with placebo and sodium aurothiomalate
24. Oral gold: A comparison with placebo and intramuscular sodium aurothiomalate
25. A 3 year follow-up of patients allocated to placebo, oral gold or injectable gold treatment for rheumatoid arthritis
26. Comparison of phenytoid and gold as second line drugs in RA
27. Proteinuria in gold treated rheumatoid arthritis
28. Gold therapy in RA report of a multicentre controlled trial
29. A risk benefit assessment of slow acting antirheumatic drugs in rheumatoid arthritis
30. Comparison of IM methotrexate and gold sodium thiomalate in the treatment of early erosive RA. 12 Month data of a double blind parallel study of 174 patients
31. Low dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis
32. Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis
33. Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients
34. Risk factors for methotrexate induced lung injury in patients with rheumatoid arthritis: A multicentre case-control study
35. Adverse events in methotrexate treated rheumatoid arthritis patients
36. Clinical, laboratory, radiographic and histopathologic features of methotrexate associated lung injury in patients with rheumatoid arthritis
37. Methotrexate for rheumatoid arthritis: Suggested guidelines for monitoring liver toxicity
38. Quantitative liver function in patients with rheumatoid arthritis treated with low dose methotrexate: A longitudinal study